Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…
Biotechnology
US, The Woodlands [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Lexicon Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDLexicon Pharmaceuticals, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Lexicon Pharmaceuticals, Inc..
If you want to see a demo, head over to the financial segments of AAPL